Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

St Jude on track for 2012 EU launch of Portico transcatheter heart valve

This article was originally published in Clinica

Executive Summary

St Jude Medical has implanted the first patient with its Portico transcatheter aortic heart valve in a European study designed to support CE mark approval. It means the company is on track to launch the valve in Europe by the end of 2012 on a limited basis; however, rival Edwards Lifesciences is likely to remain the leader in the transcatheter aortic valve implantation (TAVI) over the long term, according to Morgan Stanley analyst David Lewis.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT098294

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel